Share This Page

News

You Might Also Like

Recent Stories

American and European Union Flags

Leqembi: Europe Checks It’s Safety; U.S. Approves Monthly Doses

The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.

On Trend

Most Popular Stories

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

A man mid-sneeze.

Is Alzheimer’s Catchy?

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.

Get The Latest Updates

Subscribe To Our Weekly Newsletter

No spam, only news and updates.

Books

Amazon Books
Amazon Books

Social Media

Categories

New Posts

Free:
Alzheimer's & Dementia
Weekly Newsletter

News, Treatments, Care Tips, Diet, Research, Diagnosis, Therapies & Prevention
News to Get at the Truth

Subscribe To Our Weekly Newsletter